Altria Research and Development Expenses 2010-2023 | MO

Altria annual/quarterly research and development expenses history and growth rate from 2010 to 2023. Research and development expenses can be defined as an expense arising from studies and product development processes.
  • Altria research and development expenses for the quarter ending December 31, 2023 were $M, a NAN% increase year-over-year.
  • Altria research and development expenses for the twelve months ending December 31, 2023 were $0M, a NAN% increase year-over-year.
  • Altria annual research and development expenses for 2023 were $0B, a NAN% decline from 2022.
  • Altria annual research and development expenses for 2022 were $0B, a NAN% decline from 2021.
  • Altria annual research and development expenses for 2021 were $0B, a NAN% decline from 2020.
Altria Annual Research and Development Expenses
(Millions of US $)
2023 $
2022 $
2021 $
2020 $
2019 $
2018 $
2017 $
2016 $
2015 $
2014 $
2013 $
2012 $
2011 $
2010 $
2009 $
Altria Quarterly Research and Development Expenses
(Millions of US $)
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Consumer Staples Tobacco Products $76.074B $24.483B
Altria has a leading portfolio of tobacco products for U.S. tobacco consumers age 21 . Altria's wholly owned subsidiaries include leading manufacturers of both combustible and smoke-free products. In combustibles, Altria owns Philip Morris USA Inc. (PM USA), the most profitable U.S. cigarette manufacturer, and John Middleton Co. (Middleton), a leading U.S. cigar manufacturer. Altria's smoke-free portfolio includes ownership of U.S. Smokeless Tobacco Company LLC (USSTC), the leading global moist smokeless tobacco (MST) manufacturer, and Helix Innovations LLC (Helix), a rapidly growing manufacturer of oral nicotine pouches. Altria also owns equity investments in Anheuser-Busch InBev SA/NV (ABI), the world's largest brewer, and Cronos Group Inc. (Cronos), a leading Canadian cannabinoid company.
Stock Name Country Market Cap PE Ratio
Philip Morris (PM) United States $152.735B 16.03
British American Tobacco (BTI) United Kingdom $67.325B 0.00
Imperial Tobacco Group (IMBBY) United Kingdom $20.501B 0.00
Universal (UVV) United States $1.315B 12.56
Turning Point Brands (TPB) United States $0.584B 11.58
22nd Century (XXII) United States $0.006B 0.00